• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

危重症时的促红细胞生成素反应

Erythropoietin response to critical illness.

作者信息

Krafte-Jacobs B, Levetown M L, Bray G L, Ruttimann U E, Pollack M M

机构信息

Department of Critical Care, Children's National Medical Center, Washington, DC 20010.

出版信息

Crit Care Med. 1994 May;22(5):821-6. doi: 10.1097/00003246-199405000-00018.

DOI:10.1097/00003246-199405000-00018
PMID:8181291
Abstract

OBJECTIVE

To examine the endogenous erythropoietin response in critically ill children with acute anemia or acute hypoxemia.

DESIGN

A prospective case study of critically ill acutely anemic, and acutely hypoxemic pediatric patients compared with control groups of critically ill nonanemic and nonhypoxemic patients and with a hemoglobin and age-matched, chronically anemic patient group.

SETTING

Multidisciplinary, tertiary, pediatric intensive care unit (ICU).

PATIENTS

Critically ill patients admitted to the pediatric ICU during an 11-month period between February 1992 and March 1993 with acute anemia (n = 21), acute hypoxemia (n = 18), or neither anemia nor hypoxemia (n = 10). Outpatients with chronic anemia (n = 21) and no acute illness were also studied as a comparison group.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Ages were equivalent among the groups and averaged 57.4 +/- 47.2 months (range 1 to 144). Acutely hypoxemic and critically ill control patients had normal hemoglobin levels. Acutely anemic patients had a hemoglobin level equivalent to chronically anemic outpatients, but lower (p < .001) hemoglobin levels than acutely hypoxemic and critically ill control patients. The serum erythropoietin concentrations in the acutely anemic group were significantly lower than erythropoietin values in the chronically anemic group (39.3 +/- 62.2 vs. 861 +/- 758 mU/mL, p < .001) and similar to erythropoietin concentrations in the critically ill control (13.5 +/- 10.5 mU/mL) and acutely hypoxemic (5.2 +/- 3.3 mU/mL) patient groups. Only ten of 49 critically ill patients had an erythropoietin concentration above normal, compared with 20 of 21 chronically anemic patients, whose erythropoietin concentrations were above normal.

CONCLUSIONS

The erythropoietin response to known physiologic stimuli is blunted in critically ill children. This blunted erythropoietin response may result in increased transfusion requirements.

摘要

目的

研究患有急性贫血或急性低氧血症的危重症儿童的内源性促红细胞生成素反应。

设计

一项对患有急性贫血、急性低氧血症的危重症儿科患者进行的前瞻性病例研究,并与非贫血和非低氧血症的危重症患者对照组以及血红蛋白和年龄匹配的慢性贫血患者组进行比较。

设置

多学科、三级儿科重症监护病房(ICU)。

患者

1992年2月至1993年3月的11个月期间入住儿科ICU的危重症患者,其中急性贫血患者(n = 21)、急性低氧血症患者(n = 18),以及既无贫血也无低氧血症的患者(n = 10)。患有慢性贫血且无急性疾病的门诊患者(n = 21)也作为对照组进行研究。

干预措施

无。

测量指标及主要结果

各组年龄相当,平均为57.4±47.2个月(范围1至144个月)。急性低氧血症和危重症对照组患者的血红蛋白水平正常。急性贫血患者的血红蛋白水平与慢性贫血门诊患者相当,但低于急性低氧血症和危重症对照组患者(p <.001)。急性贫血组的血清促红细胞生成素浓度显著低于慢性贫血组(39.3±62.2对861±758 mU/mL,p <.001),与危重症对照组(13.5±10.5 mU/mL)和急性低氧血症组(5.2±3.3 mU/mL)患者的促红细胞生成素浓度相似。49例危重症患者中只有10例促红细胞生成素浓度高于正常,而21例慢性贫血患者中有20例促红细胞生成素浓度高于正常。

结论

危重症儿童对已知生理刺激的促红细胞生成素反应减弱。这种促红细胞生成素反应减弱可能导致输血需求增加。

相似文献

1
Erythropoietin response to critical illness.危重症时的促红细胞生成素反应
Crit Care Med. 1994 May;22(5):821-6. doi: 10.1097/00003246-199405000-00018.
2
Anemia in the critically ill.危重症患者的贫血
Crit Care Clin. 2004 Apr;20(2):159-78. doi: 10.1016/j.ccc.2004.01.002.
3
Serum erythropoietin levels in elderly inpatients with anemia of chronic disorders and iron deficiency anemia.老年慢性疾病性贫血和缺铁性贫血住院患者的血清促红细胞生成素水平
J Am Geriatr Soc. 1993 Dec;41(12):1301-4. doi: 10.1111/j.1532-5415.1993.tb06479.x.
4
Anemia and red blood cell transfusion in the critically ill.危重症患者的贫血与红细胞输注
Semin Dial. 2006 Nov-Dec;19(6):513-6. doi: 10.1111/j.1525-139X.2006.00214.x.
5
Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.危重症患者每周一次皮下注射促红细胞生成素α的药代动力学和药效学:一项随机、双盲、安慰剂对照试验的结果
Crit Care Med. 2006 Jun;34(6):1661-7. doi: 10.1097/01.CCM.0000217919.22155.85.
6
A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit.一项关于入住重症监护病房的贫血重症患者促红细胞生成素刺激剂使用情况的美国多中心回顾性观察研究。
Clin Ther. 2008 Dec;30(12):2324-34. doi: 10.1016/j.clinthera.2008.12.024.
7
Erythropoietin therapy in children with bronchiolitis and anemia.红细胞生成素治疗小儿细支气管炎合并贫血
Pediatr Crit Care Med. 2003 Jan;4(1):44-8. doi: 10.1097/00130478-200301000-00008.
8
Outcomes of Protocol-Driven Care of Critically Ill Severely Anemic Patients for Whom Blood Transfusion Is Not an Option.对于无法进行输血治疗的重症严重贫血患者,采用方案驱动式护理的效果。
Crit Care Med. 2016 Jun;44(6):1109-15. doi: 10.1097/CCM.0000000000001599.
9
Vascular endothelial growth factor as marker for tissue hypoxia and transfusion need in anemic infants: a prospective clinical study.
Pediatrics. 2009 Mar;123(3):784-90. doi: 10.1542/peds.2007-2304.
10
Erythropoietin response in critically ill mechanically ventilated patients: a prospective observational study.危重症机械通气患者的促红细胞生成素反应:一项前瞻性观察性研究。
Crit Care. 2005 Jun;9(3):R172-6. doi: 10.1186/cc3480. Epub 2005 Feb 25.

引用本文的文献

1
Iron and erythropoietin to heal and recover after intensive care (ITHRIVE): A pilot randomised clinical trial.重症监护后使用铁剂和促红细胞生成素促进愈合与恢复(ITHRIVE):一项试点随机临床试验。
Crit Care Resusc. 2023 Dec 14;25(4):201-206. doi: 10.1016/j.ccrj.2023.10.007. eCollection 2023 Dec.
2
Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis.重症监护病房患者接受促红细胞生成刺激剂治疗的安全性和疗效:系统评价和荟萃分析。
Intensive Care Med. 2019 Sep;45(9):1190-1199. doi: 10.1007/s00134-019-05686-y. Epub 2019 Jul 11.
3
Harms of off-label erythropoiesis-stimulating agents for critically ill people.
危重症患者使用非标签促红细胞生成素刺激剂的危害。
Cochrane Database Syst Rev. 2017 Aug 25;8(8):CD010969. doi: 10.1002/14651858.CD010969.pub2.
4
Hemoglobin Threshold for Blood Transfusion in a Pediatric Intensive Care Unit.儿科重症监护病房输血的血红蛋白阈值
Transfus Med Hemother. 2016 Jul;43(4):297-301. doi: 10.1159/000446253. Epub 2016 May 23.
5
Anaemia secondary to critical illness: an unexplained phenomenon.危重症继发贫血:一种无法解释的现象。
Extrem Physiol Med. 2014 Feb 7;3(1):4. doi: 10.1186/2046-7648-3-4.
6
Anemia among Pediatric Critical Care Survivors: Prevalence and Resolution.儿科重症监护幸存者中的贫血:患病率与转归
Crit Care Res Pract. 2013;2013:684361. doi: 10.1155/2013/684361. Epub 2013 Feb 27.
7
Anemia of thermal injury: combined acute blood loss anemia and anemia of critical illness.热损伤性贫血:合并急性失血性贫血和危重症贫血。
J Burn Care Res. 2010 Mar-Apr;31(2):229-42. doi: 10.1097/BCR.0b013e3181d0f618.
8
A review of red cell transfusion in the neurological intensive care unit.神经重症监护病房红细胞输血综述
Neurocrit Care. 2006;4(1):63-7. doi: 10.1385/NCC:4:1:063.
9
Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice.重症监护期间及出院时的贫血:限制性输血策略的影响。
Intensive Care Med. 2006 Jan;32(1):100-9. doi: 10.1007/s00134-005-2855-2. Epub 2005 Nov 23.
10
Erythropoietin response in critically ill mechanically ventilated patients: a prospective observational study.危重症机械通气患者的促红细胞生成素反应:一项前瞻性观察性研究。
Crit Care. 2005 Jun;9(3):R172-6. doi: 10.1186/cc3480. Epub 2005 Feb 25.